| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
51,320,000 |
| Market
Cap: |
4.72(B) |
| Last
Volume: |
548,324 |
Avg
Vol: |
491,730 |
| 52
Week Range: |
$71.24 - $93.49 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P SMALLCAP 600 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 438 |
| Guru Rank Value : 3.1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Haemonetics is a global healthcare company providing a suite of medical products and solutions for customers. Co.'s technology addresses medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. Co. has three principal reporting segments: Plasma, which provides automated plasma collection and donor management software systems; Blood Center, which provides a range of solutions that improve donor collection centers' ability to collect and filter blood and separate blood components; and Hospital, which has four product lines, including Hemostasis Management, Vascular Closure, Transfusion Management and Cell Salvage.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
22,518 |
91,806 |
| Total Sell Value |
$0 |
$0 |
$1,982,727 |
$7,138,305 |
| Total People Sold |
0 |
0 |
4 |
9 |
| Total Sell Transactions |
0 |
0 |
6 |
33 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Basil Michelle L |
EVP and General Counsel |
• • – |
2022-05-16 |
4 |
S |
$56.10 |
$10,996 |
D/D |
(196) |
38,094 |
|
-25% |
|
| Darecca James |
EVP, Chief Financial Officer |
• • – |
2022-05-02 |
4 |
A |
$0.00 |
$0 |
D/D |
5,902 |
5,902 |
|
- |
|
| Lingamneni Anila |
EVP, Chief Technology Officer |
• • – |
2022-04-18 |
4 |
S |
$56.55 |
$10,688 |
D/D |
(189) |
14,013 |
|
-32% |
|
| Strong Stewart W |
President, Global Hospital |
• • – |
2021-10-25 |
4 |
S |
$71.93 |
$5,395 |
D/D |
(75) |
12,717 |
|
18% |
|
| Basil Michelle L |
EVP and General Counsel |
• • – |
2021-10-25 |
4 |
S |
$71.93 |
$8,632 |
D/D |
(120) |
38,290 |
|
18% |
|
| Miller Laurie A. |
SVP, Human Resources |
• – – |
2021-09-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,848 |
10,081 |
|
- |
|
| Llorens Josep |
EVP, Global Manufacturing |
• – – |
2021-09-07 |
4 |
S |
$64.61 |
$6,461 |
D/D |
(100) |
14,520 |
|
20% |
|
| Miller Laurie A. |
SVP, Human ResourcesOfficer |
• – – |
2021-08-30 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
7,233 |
|
- |
|
| Miller Laurie A. |
SVP, Human ResourcesOfficer |
• – – |
2021-08-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,199 |
|
-15% |
|
| Burke Willaim P |
EVP, Chief Financial Officer |
• – – |
2021-08-23 |
4 |
AS |
$60.51 |
$1,371,580 |
D/D |
(22,667) |
30,291 |
|
-10% |
|
| Burke Willaim P |
EVP, Chief Financial Officer |
• – – |
2021-08-23 |
4 |
OE |
$34.21 |
$860,400 |
D/D |
22,667 |
52,958 |
|
- |
|
| Nikel Chad M. |
President, Global Plasma & BCO |
• – – |
2021-08-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
17,336 |
|
-13% |
|
| Strong Stewart W |
President, Global HospitalOffi |
• – – |
2021-08-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,792 |
|
-13% |
|
| Burzik Catherine M |
Director |
• • – |
2021-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,077 |
16,815 |
|
- |
|
| Kroll Mark W |
Director |
• • – |
2021-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,077 |
21,517 |
|
- |
|
| Abernathy Robert E |
Director |
• • – |
2021-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,077 |
15,125 |
|
- |
|
| Johnson Lloyd Emerson |
Director |
• • – |
2021-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,077 |
3,077 |
|
- |
|
| Dockendorff Charles J |
Director |
• • – |
2021-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,077 |
25,400 |
|
- |
|
| Zane Ellen M |
Director |
• • – |
2021-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,077 |
9,517 |
|
- |
|
| Coyle Michael J |
Director |
• • – |
2021-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,077 |
5,538 |
|
- |
|
| Pomeroy Claire |
Director |
• • – |
2021-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,077 |
7,016 |
|
- |
|
| Burke Willaim P |
EVP, Chief Financial Officer |
• • – |
2021-07-01 |
4 |
AS |
$66.60 |
$285,914 |
D/D |
(4,293) |
30,291 |
|
5% |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2021-06-07 |
4 |
S |
$55.09 |
$4,462 |
D/D |
(81) |
4,093 |
|
-24% |
|
| Scanlan Jacqueline |
SVP, Global Human Resources |
• • – |
2021-06-07 |
4 |
S |
$55.09 |
$10,743 |
D/D |
(195) |
4,216 |
|
-24% |
|
| Basil Michelle L |
EVP and General Counsel |
• • – |
2021-06-07 |
4 |
S |
$55.09 |
$24,350 |
D/D |
(442) |
38,605 |
|
-24% |
|
1310 Records found
|
|
Page 5 of 53 |
|
|
0.45 (0.49%) 
